Fu Bopeng and Li Jing, two star fund managers, have also reduced their holdings of Hangdian Group. At present, the main assets of Tian Zi Science and Technology have been suspended. According to the list of the top ten shareholders, Tian Zi Science and Technology's Time Report also has certain value, ranking among the five or six tradable shareholders. As of June, the above three funds have completely withdrawn from the list of shareholders. This means that there will be a significant reduction in the second quarter. According to public information, due to relatively low performance, mergers and acquisitions and transformation will occur.
Judging from these stock prices, Huitai Medical has become a V-shaped trend in the first half of this year. The stock price was low in April, having fallen by 45% before. By June 24, it had rebounded by 50%, with an increase of 20.9% during the year. Such signs of bargain-hunting are more obvious. According to public information, the production and sales of Huitai Medical Company include physiological medical machinery, and the overall performance of Huitai Medical has grown very well. According to the actual income has reached 829 million yuan, and the net profit is 208 million yuan, so the company's operating income is still very optimistic.
The market is still confused. Compared with assets and performance, Shanghai's valuation is also very high. On April 30th, Shanghai's asset appraisal report showed all the income, with a value of 65.438+60.6 million yuan. There will be different inquiry letters about this. The net profit requirement of Huitai Medical is negative. The core of Huitai Medical means that the brand's influence, customers' business and business model, quality personnel and management team will be improved.